This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignees: Masaryk Memorial Cancer Institute, The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of Dundee. Active years: 2012-2018.
Location History:
- Brno, CZ (2013)
- Modrice, CZ (2012 - 2018)
Company Filing History:
3 out of 3 
3 out of 3,690 
3 out of 108 
Years Active: 2012-2018
Title: Inventor Borivoj Vojtesek: Pioneering Research in Regenerative Medicine
Introduction
Borivoj Vojtesek, a distinguished inventor based in Modrice, Czech Republic, has made significant contributions to the fields of regenerative medicine, aging, and cancer research. With a portfolio of five patents, Vojtesek's innovative work focuses on the therapeutic applications of p53 isoforms, a critical area of study that holds promise for future medical advancements.
Latest Patents
Among Borivoj Vojtesek's most notable patents is his exploration of therapeutic applications of p53 isoforms in regenerative medicine, aging, and cancer. The inventions provide methods and compositions aimed at modulating cell senescence and cell proliferation using isoforms of the p53 tumor suppressor protein. These inventive approaches are designed to inhibit cancer cell growth and can generate populations of cells conducive to tissue regeneration through the modulation of both cell senescence and proliferation.
Career Highlights
Vojtesek's impressive career includes positions at renowned institutions such as the University of Dundee and the Masaryk Memorial Cancer Institute. His work in these esteemed establishments has solidified his reputation as a leading figure in cancer research and regenerative medicine.
Collaborations
Throughout his career, Borivoj Vojtesek has collaborated with prominent researchers, including Curtis C. Harris and Kaori Fujita. These partnerships have fostered innovative research efforts and have led to significant advancements in understanding the role of p53 in cancer biology and regenerative processes.
Conclusion
Borivoj Vojtesek continues to be a key player in the realm of medical innovation. His patents, particularly concerning the therapeutic applications of p53 isoforms, demonstrate his commitment to advancing the field of regenerative medicine. Through his collaborative efforts and innovative research, Vojtesek is paving the way for potential breakthroughs in treating cancer and enhancing tissue regeneration.